Home › Compare › NEPT vs EQR

NEPT vs EQR: Dividend Comparison 2026

NEPT yields 1000.00% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEPT wins by $18844438.64M in total portfolio value
10 years
NEPT
NEPT
● Live price
1000.00%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18844438.68M
Annual income
$15,746,803,993,532.36
Full NEPT calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — NEPT vs EQR

📍 NEPT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEPTEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEPT + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NEPT pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEPT
Annual income on $10K today (after 15% tax)
$85,000.00/yr
After 10yr DRIP, annual income (after tax)
$13,384,783,394,502.51/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, NEPT beats the other by $13,384,783,391,255.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEPT + EQR for your $10,000?

NEPT: 50%EQR: 50%
100% EQR50/50100% NEPT
Portfolio after 10yr
$9422219.36M
Annual income
$7,873,401,998,675.98/yr
Blended yield
83.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

NEPT
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-5971.0
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEPT buys
0
EQR buys
0
No recent congressional trades found for NEPT or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEPTEQR
Forward yield1000.00% ✓4.73%
Annual dividend / share$2.00$2.77 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$18844438.68M ✓$40.5K
Annual income after 10y$15,746,803,993,532.36 ✓$3,819.61
Total dividends collected$18607754.73M ✓$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: NEPT vs EQR ($10,000, DRIP)

YearNEPT PortfolioNEPT Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$110,700$100,000.00$11,248$547.57+$99.5K → NEPT
2$1,153,028$1,034,579.44$12,701$666.53+$1.14M → NEPT
3$11,304,737$10,070,996.94$14,405$814.59+$11.29M → NEPT
4$104,376,400$92,280,331.11$16,413$999.84+$104.36M → NEPT
5$907,965,307$796,282,558.81$18,795$1,232.92+$907.95M → NEPT
6$7,445,190,031$6,473,667,152.78$21,639$1,527.95+$7445.17M → NEPT
7$57,576,798,154$49,610,444,821.11$25,057$1,903.80+$57576.77M → NEPT
8$420,166,535,918$358,559,361,892.40$29,197$2,385.87+$420166.51M → NEPT
9$2,894,985,686,808$2,445,407,493,376.48$34,250$3,008.70+$2894985.65M → NEPT
10$18,844,438,678,417$15,746,803,993,532.36$40,467$3,819.61+$18844438.64M → NEPT

NEPT vs EQR: Complete Analysis 2026

NEPT — Stock

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.

Full NEPT Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this NEPT vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEPT vs SCHDNEPT vs JEPINEPT vs ONEPT vs KONEPT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.